SRRK Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $46.81

Market Cap (MRQ) $5.69B

P/E (TTM) -14.1

EPS (TTM) $-3.31

Revenue (TTM) $0

ROE (TTM) -167.8%

Debt/Equity (MRQ) 0.8

52W Range $27–$62

SRRK Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$0

2018-12-31 → 2025-12-31

EPS$-3.29

2020-12-31 → 2025-12-31

Free Cash Flow$-301M

2018-12-31 → 2025-12-31

Net margin·

2019-12-31 → 2022-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	SRRK	5Y avg	Peer Median	Verdict
P/E (TTM)	-14.15Y avg ≈-10.3	≈-10.3	·	·
P/B (MRQ)	22.45Y avg ≈8.7	≈8.7	11.6	Overvalued
EV / EBITDA	-12.55Y avg ≈-8.0	≈-8.0	·	·
Price / FCF (TTM)	-19.25Y avg ≈-11.2	≈-11.2	·	·
Price / Cash Flow (TTM)	-19.25Y avg ≈-11.3	≈-11.3	·	·
EV / FCF (TTM)	-18.25Y avg ≈-9.6	≈-9.6	·	·
Price / Tangible Book	20.75Y avg ≈8.7	≈8.7	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	5Y trend	SRRK	5Y avg	Peer Median	Verdict
ROA (TTM)		-94.6%5Y avg ≈-55.4%	≈-55.4%	-23.8%	Weak
ROE (TTM)		-167.8%5Y avg ≈-94.8%	≈-94.8%	-34.6%	Weak

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	SRRK	5Y avg	Peer Median	Verdict
Debt / Equity (MRQ)	0.85Y avg ≈0.2	≈0.2	0.5	High debt
Current Ratio (MRQ)	7.05Y avg ≈7.7	≈7.7	7.3	Low liquidity
Quick Ratio	6.65Y avg ≈7.4	≈7.4	3.1	Strong liquidity
Long-Term Debt / Equity (MRQ)	0.85Y avg ≈0.2	≈0.2	0.5	High debt

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	SRRK	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-3.295Y avg ≈$-2.72	≈$-2.72	·	·
Revenue / Share	$0.005Y avg ≈$0.36	≈$0.36	·	·
Cash Flow / Share	$-2.625Y avg ≈$-2.41	≈$-2.41	·	·
Cash / Share	$2.985Y avg ≈$2.85	≈$2.85	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	5Y trend	SRRK	5Y avg	Peer Median	Verdict
Asset Turnover		0.05Y avg ≈0.1	≈0.1	0.0	Weak
Revenue / Employee		≈$0.00	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise -7.6%

Next Report Nov 12, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Aug 12, 2026	$-0.84	$-0.86	2.0%
March 31, 2026	May 12, 2026	$-0.83	$-0.82	-1.6%
Dec. 31, 2025		$-0.88	$-0.91	3.1%
Sept. 30, 2025		$-0.90	$-0.86	-5.2%
June 30, 2025		$-0.98	$-0.68	-44.6%
March 31, 2025		$-0.67	$-0.67	0.64%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 12

Metric	2025	2024	2023	2022	2021	2020	2019	2018
Revenue	$0	·	·	$33M	$19M	$15M	$20M	$0
R&D Expense	$208M	$185M	$122M	$124M	$108M	$74M	$54M	$36M
SG&A Expense	$176M	$68M	$49M	$43M	$40M	$28M	$21M	$14M
Operating Expenses	$385M	$252M	$171M	$168M	$149M	$102M	$75M	$51M
Operating Income	$-385M	$-252M	$-171M	$-134M	$-130M	$-87M	$-55M	$-51M
Other Non-op	$-301.0K	$-85.0K	$6M	$-132.0K	$-2M	$395.0K	$4M	$1M
Net Income	$-378M	$-246M	$-166M	$-135M	$-132M	$-86M	$-51M	$-49M
EPS (Basic)	$-3.29	$-2.47	$-1.99	$-2.26	$-3.59	$-2.81	·	·
EPS (Diluted)	$-3.29	$-2.47	$-1.99	$-2.26	$-3.59	$-2.81	·	·
Shares (Basic)	114,701,154	99,838,102	83,347,086	59,611,656	36,711,833	30,734,109	·	·
Shares (Diluted)	114,701,154	99,838,102	83,347,086	59,611,656	36,711,833	30,734,109	·	·
EBITDA	$-385M	$-252M	$-171M	$-134M	$-130M	$-87M	$-55M	$-51M

Balance Sheet 26

Metric	2025	2024	2023	2022	2021	2020	2019	2018
Cash & Equivalents	$324M	$178M	$102M	$103M	$213M	$160M	$36M	$115M
Short-term Investments	$44M	$259M	$178M	$212M	$40M	$181M	$121M	$61M
Receivables	·	·	·	·	·	·	$25M	·
Prepaid Expense	$18M	$14M	$8M	$13M	$12M	$3M	$3M	$2M
Current Assets	$385M	$451M	$288M	$328M	$265M	$344M	$185M	$178M
PP&E (Net)	$2M	$3M	$5M	$7M	$10M	$8M	$4M	$3M
PP&E (Gross)	$17M	$16M	$16M	$18M	$17M	$13M	$8M	$6M
Accum. Depreciation	$15M	$13M	$11M	$10M	$7M	$5M	$4M	$2M
Other Non-current Assets	$3M	$3M	$4M	$2M	$2M	$1M	$98.0K	·
Total Assets	$404M	$475M	$311M	$358M	$304M	$388M	$196M	$181M
Accounts Payable	$10M	$10M	$3M	$4M	$4M	$3M	$1M	$3M
Accrued Liabilities	$40M	$31M	$20M	$24M	$17M	$15M	$10M	$7M
Short-term Debt	·	·	$1M	·	$2M	·	·	·
Current Liabilities	$55M	$47M	$33M	$36M	$64M	$43M	$33M	$31M
Capital Leases	$4M	$9M	$4M	$12M	$20M	$27M	$4M	·
Other Non-current Liabilities	·	·	·	·	·	$5.0K	$9.0K	·
Total Liabilities	$159M	$106M	$86M	$98M	$132M	$128M	$83M	$75M
Long-term Debt	·	·	$51M	$51M	$52M	$26M	·	·
Total Debt	$100M	$50M	$50M	$50M	$50M	$25M	·	·
Common Stock	$108.0K	$94.0K	$76.0K	$52.0K	$35.0K	$34.0K	$30.0K	$26.0K
Paid-in Capital	$1.55B	$1.29B	$901M	$772M	$548M	$505M	$271M	$213M
Retained Earnings	$-1.30B	$-923M	$-676M	$-511M	$-376M	$-244M	$-158M	$-107M
AOCI	$94.0K	$160.0K	$92.0K	$-884.0K	$-35.0K	$-2.0K	$37.0K	$-8.0K
Stockholders' Equity	$245M	$369M	$225M	$260M	$172M	$261M	$113M	$107M
Liabilities + Equity	$404M	$475M	$311M	$358M	$304M	$388M	$196M	$181M
Shares Outstanding	108,461,354	93,823,678	75,979,495	51,672,579	35,209,099	34,152,470	29,792,922	26,217,701

Cash Flow 13

Metric	2025	2024	2023	2022	2021	2020	2019	2018
D&A	$2M	$2M	$3M	$3M	$3M	$1M	$1M	$800.0K
Stock-based Comp	$76M	$37M	$27M	$28M	$23M	$11M	$8M	$5M
Operating Cash Flow	$-300M	$-201M	$-145M	$-133M	$-127M	$-60M	$-63M	$25M
CapEx	$602.0K	$98.0K	$71.0K	$1M	$5M	$4M	$3M	$1M
Investing Cash Flow	$219M	$-76M	$41M	$-172M	$134M	$-63M	$-62M	$-60M
Debt Issued	$25M	·	·	·	·	·	·	·
Net Debt Issued	$-852.0K	·	·	·	·	·	·	·
Stock Issued	$92M	$324M	$98M	$195M	$13M	$216M	$48M	$95M
Net Stock Activity	$92M	$324M	$98M	$195M	$13M	$216M	$48M	$17M
Financing Cash Flow	$228M	$353M	$103M	$195M	$45M	$248M	$49M	$94M
Net Change in Cash	·	$76M	$-2M	$-110M	$52M	$124M	$-76M	$59M
Taxes Paid	$46.0K	·	·	·	·	·	·	·
Free Cash Flow	$-301M	$-201M	$-145M	$-134M	$-132M	$-64M	$-66M	$23M

Profitability 5

Metric	2025	2024	2023	2022	2021	2020	2019	2018
Operating Margin	·	·	·	-404.8%	-690.5%	-564.0%	-266.2%	·
Net Margin	·	·	·	-405.2%	-700.5%	-561.5%	-248.9%	·
EBITDA Margin	·	·	·	-404.8%	-690.5%	-564.0%	-266.2%	·
ROA	-86.0%	-62.7%	-49.5%	-40.6%	-38.0%	-29.6%	-27.0%	-40.6%
ROE	-157.9%	-110.0%	-84.4%	-48.6%	-73.4%	-53.4%	-43.5%	-47.2%

Liquidity & Solvency 4

Metric	2025	2024	2023	2022	2021	2020	2019	2018
Current Ratio	6.9	9.6	8.8	9.0	4.1	8.1	5.6	5.7
Quick Ratio	6.6	9.3	8.6	8.7	3.9	8.0	5.6	5.6
Debt / Equity	0.4	0.1	0.2	0.2	0.3	0.1	·	·
LT Debt / Equity	0.4	0.1	0.2	0.2	0.3	0.1	·	·

Efficiency 2

Metric	Trend	2025	2024	2023	2022	2021	2020	2019	2018
Asset Turnover		0.0	·	·	0.1	0.1	0.1	0.1	0.0
Receivables Turnover		·	·	·	·	·	·	1.6	·

Per Share 5

Metric	2025	2024	2023	2022	2021	2020	2019	2018
Book Value / Share	$2.26	$3.93	$2.96	$5.04	$4.89	$7.64	$3.79	$4.07
Revenue / Share	$0.00	·	·	$0.56	$0.51	·	·	·
Cash Flow / Share	$-2.62	$-2.01	$-1.74	$-2.23	$-3.45	·	·	·
Cash / Share	$2.98	$1.90	$1.34	$2.00	$6.04	$4.70	$1.22	$4.39
EPS (TTM)	$-3.29	$-2.47	$-1.99	$-2.26	$-3.59	$-2.81	·	·

Growth Rates 1

Metric	Trend	2025	2024	2023	2022	2021	2020	2019	2018
Revenue YoY		·	·	·	76.4%	22.2%	·	·	·

Valuation (TTM) 14

Metric	2025	2024	2023	2022	2021	2020	2019	2018
Revenue TTM	$0	$48M	$48M	$33M	$19M	$15M	$20M	$0
Net Income TTM	$-378M	$-246M	$-166M	$-135M	$-132M	$-86M	$-51M	$-49M
Market Cap	$4.78B	$4.06B	$1.43B	$468M	$875M	$1.66B	$393M	$602M
Enterprise Value	$4.51B	$3.67B	$1.20B	$202M	$672M	$1.34B	·	·
P/E	-13.4	-17.5	-9.4	-4.0	-6.9	-17.3	·	·
P/S	·	84.6	29.8	14.1	46.5	107.6	19.2	·
P/B	19.5	11.0	6.3	1.8	5.1	6.4	3.5	5.6
P / Tangible Book	19.5	11.0	6.3	1.8	5.1	6.4	·	·
P / Cash Flow	-15.9	-20.2	-9.8	-3.5	-6.9	-27.5	-6.2	24.5
P / FCF	-15.9	-20.2	-9.8	-3.5	-6.6	-25.8	-5.9	26.1
EV / EBITDA	-11.7	-14.6	-7.0	-1.5	-5.2	-15.4	·	·
EV / FCF	-15.0	-18.2	-8.2	-1.5	-5.1	-20.8	·	·
EV / Revenue	·	76.5	25.0	6.1	35.7	87.1	·	·
Earnings Yield	-7.5%	-5.7%	-10.6%	-25.0%	-14.4%	-5.8%	·	·

Income Statement 12

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$0	$0	$0	$0	·	·	·	·	·	·	·	·	·	·	$0	$0
R&D Expense	$58M	$52M	$47M	$50M	$62M	$49M	$50M	$49M	$42M	$43M	$35M	$30M	$27M	$30M	$30M	$33M
SG&A Expense	$51M	$50M	$45M	$53M	$50M	$28M	$19M	$16M	$17M	$15M	$13M	$13M	$12M	$11M	$11M	$10M
Operating Expenses	$109M	$102M	$92M	$104M	$112M	$77M	$69M	$65M	$59M	$58M	$48M	$44M	$39M	$41M	$40M	$44M
Operating Income	$-109M	$-102M	$-92M	$-104M	$-112M	$-77M	$-69M	$-65M	$-59M	$-58M	$-48M	$-44M	$-39M	$-41M	$-40M	$-44M
Other Non-op	$-570.0K	$-790.0K	$-2M	$-69.0K	$-127.0K	$-44.0K	$-2M	$-38.0K	$-14.0K	$2M	$2M	$1M	$1M	$1M	$1M	$565.0K
Net Income	$-110M	$-106M	$-91M	$-102M	$-110M	$-75M	$-66M	$-64M	$-59M	$-57M	$-46M	$-42M	$-38M	$-39M	$-39M	$-43M
EPS (Basic)	$-0.84	$-0.83	$-0.74	$-0.90	$-0.98	$-0.67	$-0.62	$-0.66	$-0.60	$-0.59	$-0.50	$-0.53	$-0.47	$-0.49	$-0.44	$-0.55
EPS (Diluted)	$-0.84	$-0.83	$-0.74	$-0.90	$-0.98	$-0.67	$-0.62	$-0.66	$-0.60	$-0.59	$-0.50	$-0.53	$-0.47	$-0.49	$-0.44	$-0.55
Shares (Basic)	130,612,734	127,277,144	·	113,729,850	112,703,014	111,838,272	·	97,050,637	96,813,116	95,892,601	·	80,606,438	80,117,983	79,610,059	·	79,336,161
Shares (Diluted)	130,612,734	127,277,144	·	113,729,850	112,703,014	111,838,272	·	97,050,637	96,813,116	95,892,601	·	80,606,438	80,117,983	79,610,059	·	79,336,161
EBITDA	$-109M	$-102M	·	$-104M	$-112M	$-77M	·	$-65M	$-59M	$-58M	·	$-44M	$-39M	$-41M	·	$-44M

Balance Sheet 23

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$437M	$431M	$324M	$287M	$153M	$138M	$178M	$76M	$93M	$92M	$102M	$68M	$108M	$151M	$103M	$133M
Short-term Investments	$55M	$49M	$44M	$83M	$142M	$226M	$259M	$63M	$97M	$146M	$178M	$151M	$141M	$124M	$212M	$211M
Prepaid Expense	$15M	$35M	$18M	$21M	$24M	$21M	$14M	$14M	$9M	$9M	$8M	$10M	$11M	$12M	$13M	$14M
Current Assets	$507M	$515M	$385M	$391M	$319M	$385M	$451M	$153M	$199M	$247M	$288M	$228M	$260M	$287M	$328M	$358M
PP&E (Net)	$1M	$1M	$2M	$2M	$2M	$3M	$3M	$3M	$4M	$4M	$5M	$5M	$6M	$7M	$7M	$8M
PP&E (Gross)	·	·	$17M	·	·	·	$16M	·	·	·	$16M	·	·	·	$18M	·
Accum. Depreciation	·	·	$15M	·	·	·	$13M	·	·	·	$11M	·	·	·	$10M	·
Other Non-current Assets	$3M	$5M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$4M	$4M	$1M	$2M	$2M	$2M	$2M
Total Assets	$524M	$535M	$404M	$412M	$340M	$408M	$475M	$179M	$227M	$267M	$311M	$251M	$285M	$315M	$358M	$390M
Accounts Payable	$11M	$9M	$10M	$7M	$1M	$4M	$10M	$4M	$3M	$3M	$3M	$2M	$3M	$4M	$4M	$2M
Accrued Liabilities	$55M	$44M	$40M	$50M	$44M	$28M	$31M	$29M	$22M	$21M	$20M	$17M	$14M	$15M	$24M	$23M
Short-term Debt	·	·	·	·	·	·	·	·	$2M	$6M	$1M	·	·	·	·	$805.0K
Current Liabilities	$72M	$60M	$55M	$62M	$50M	$38M	$47M	$39M	$33M	$38M	$33M	$27M	$24M	$26M	$36M	$34M
Capital Leases	$1M	$3M	$4M	$5M	$7M	$8M	$9M	$10M	$12M	$2M	$4M	$6M	$8M	$10M	$12M	$14M
Total Liabilities	$270M	$259M	$159M	$167M	$107M	$95M	$106M	$100M	$93M	$85M	$86M	$83M	$82M	$86M	$98M	$97M
Total Debt	$196M	$197M	·	$100M	$50M	$50M	·	$50M	$50M	$50M	·	$50M	$50M	$50M	·	$51M
Common Stock	$122.0K	$119.0K	$108.0K	$99.0K	$96.0K	$95.0K	$94.0K	$80.0K	$80.0K	$80.0K	$76.0K	$56.0K	$55.0K	$52.0K	$52.0K	$52.0K
Paid-in Capital	$1.77B	$1.68B	$1.55B	$1.45B	$1.34B	$1.31B	$1.29B	$935M	$925M	$916M	$901M	$798M	$790M	$779M	$772M	$766M
Retained Earnings	$-1.52B	$-1.41B	$-1.30B	$-1.21B	$-1.11B	$-997M	$-923M	$-856M	$-792M	$-733M	$-676M	$-630M	$-588M	$-550M	$-511M	$-471M
AOCI	$1M	$690.0K	$94.0K	$117.0K	$58.0K	$129.0K	$160.0K	$128.0K	$-54.0K	$-50.0K	$92.0K	$-23.0K	$-63.0K	$-329.0K	$-884.0K	$-936.0K
Stockholders' Equity	$254M	$276M	$245M	$245M	$233M	$312M	$369M	$79M	$134M	$183M	$225M	$168M	$203M	$229M	$260M	$293M
Liabilities + Equity	$524M	$535M	$404M	$412M	$340M	$408M	$475M	$179M	$227M	$267M	$311M	$251M	$285M	$315M	$358M	$390M
Shares Outstanding	121,600,396	119,103,774	108,461,354	99,171,486	95,999,608	94,873,407	93,823,678	80,081,535	79,992,068	79,744,654	75,979,495	56,260,574	55,159,787	51,989,359	51,672,579	51,660,854

Cash Flow 12

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$297.0K	$335.0K	$425.0K	$423.0K	$417.0K	$393.0K	$395.0K	$446.0K	$498.0K	$598.0K	$672.0K	$708.0K	$731.0K	$733.0K	$749.0K	$744.0K
Stock-based Comp	$20M	$18M	$19M	$18M	$24M	$13M	$10M	$10M	$9M	$8M	$7M	$7M	$7M	$6M	$6M	$8M
Operating Cash Flow	$-70M	$-82M	$-75M	$-69M	$-77M	$-79M	$-50M	$-52M	$-49M	$-50M	$-37M	$-32M	$-33M	$-43M	$-29M	$-26M
CapEx	$1.0K	$68.0K	$32.0K	$84.0K	$215.0K	$271.0K	$22.0K	$31.0K	$22.0K	$23.0K	$0	$0	$41.0K	$30.0K	$117.0K	$27.0K
Investing Cash Flow	$-6M	$-5M	$39M	$60M	$85M	$35M	$-195M	$35M	$51M	$33M	$-25M	$-8M	$-15M	$90M	$77.0K	$-146M
Debt Issued	·	·	$0	$0	$1.0K	$25M	·	·	·	·	·	·	·	·	·	·
Net Debt Issued	·	$-103M	·	·	·	$-853.0K	·	·	·	·	·	·	·	·	·	·
Stock Issued	$63M	$98M	$2.0K	$92M	·	·	·	·	·	·	$92M	$0	$4M	$827.0K	$0	$-455.0K
Net Stock Activity	·	$98M	·	·	·	·	·	·	·	·	·	·	·	$827.0K	·	·
Financing Cash Flow	$83M	$194M	$73M	$144M	$6M	$4M	$346M	$166.0K	$-33.0K	$7M	$97M	$280.0K	$5M	$1M	$-970.0K	$-451.0K
Net Change in Cash	·	·	·	$135M	$15M	$-40M	·	$-17M	$1M	$-10M	$34M	$-40M	$-43M	$48M	$-30M	$-173M
Free Cash Flow	·	$-82M	·	·	·	$-79M	·	·	·	$-50M	·	·	·	$-43M	·	·

Profitability 2

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
ROA		-25.4%	-22.4%	·	-34.6%	-38.8%	-22.1%	·	-30.0%	-22.9%	-19.5%	·	-13.2%	-10.7%	-13.6%	·	-12.6%
ROE		-45.1%	-35.9%	·	-63.1%	-60.0%	-30.2%	·	-52.2%	-34.8%	-27.6%	·	-18.4%	-14.3%	-19.7%	·	-18.0%

Liquidity & Solvency 4

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	7.0	8.6	·	6.3	6.3	10.3	·	3.9	6.0	6.6	·	8.5	10.7	11.0	·	10.6
Quick Ratio	6.8	8.0	·	6.0	5.8	9.7	·	3.5	5.8	6.4	·	8.2	10.2	10.5	·	10.2
Debt / Equity	0.8	0.7	·	0.4	0.2	0.2	·	0.6	0.4	0.3	·	0.3	0.2	0.2	·	0.2
LT Debt / Equity	0.8	0.7	·	0.4	0.2	0.2	·	0.6	0.4	0.2	·	0.3	0.2	0.2	·	0.2

Efficiency 1

Metric	Trend	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		·	0.0	·	·	·	·	·	·	·	·	·	·	·	·	·	·

Per Share 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$2.09	$2.32	·	$2.47	$2.43	$3.29	·	$0.99	$1.67	$2.29	·	$2.98	$3.67	$4.40	·	$5.68
Revenue / Share	·	$0.00	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Cash Flow / Share	·	$-0.65	·	·	·	$-0.70	·	·	·	$-0.52	·	·	·	$-0.54	·	·
Cash / Share	$3.59	$3.61	·	$2.89	$1.59	$1.45	·	$0.95	$1.17	$1.15	·	$1.20	$1.96	$2.91	·	$2.58
EPS (TTM)	$-3.31	$-3.45	·	$-3.17	$-2.93	$-2.55	·	$-2.35	$-2.22	$-2.09	·	$-1.93	$-1.95	$-2.54	·	$-2.79

Valuation (TTM) 11

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$0	·	·	·	$33M	$33M	·	$33M	$33M	$33M	·	$33M	$33M	$33M	·	$37M
Net Income TTM	$-409M	$-409M	·	$-353M	$-316M	$-264M	·	$-226M	$-204M	$-183M	·	$-159M	$-160M	$-166M	·	$-131M
Market Cap	$6.69B	$5.86B	·	$3.69B	$3.40B	$3.05B	·	$641M	$666M	$1.42B	·	$399M	$416M	$416M	·	$358M
Enterprise Value	$6.39B	$5.57B	·	$3.42B	$3.16B	$2.74B	·	$552M	$526M	$1.23B	·	$231M	$217M	$190M	·	$65M
P/E	-16.6	-14.2	·	-11.7	-12.1	-12.6	·	-3.4	-3.8	-8.5	·	-3.7	-3.9	-3.1	·	-2.5
P/S	·	·	·	·	102.4	91.9	·	19.3	20.1	42.7	·	12.0	12.5	12.5	·	9.6
P/B	26.4	21.2	·	15.1	14.6	9.8	·	8.1	5.0	7.7	·	2.4	2.1	1.8	·	1.2
P / Tangible Book	26.4	21.2	·	15.1	14.6	9.8	·	8.1	5.0	7.7	·	2.4	2.1	1.8	·	1.2
P / Cash Flow	·	-71.3	·	·	·	-38.8	·	·	·	-28.4	·	·	·	-9.7	·	·
EV / Revenue	·	·	·	·	95.1	82.4	·	16.6	15.8	37.0	·	7.0	6.5	5.7	·	1.7
Earnings Yield	-6.0%	-7.0%	·	-8.5%	-8.3%	-7.9%	·	-29.3%	-26.7%	-11.8%	·	-27.2%	-25.9%	-31.8%	·	-40.3%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$0	·	·	$33M	$19M
Operating Margin %	·	·	·	-404.8%	-690.5%
Net Income	$-378M	$-246M	$-166M	$-135M	$-132M
Diluted EPS	$-3.29	$-2.47	$-1.99	$-2.26	$-3.59

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debt / Equity	0.4	0.1	0.2	0.2	0.3
Current Ratio	6.9	9.6	8.8	9.0	4.1
Quick Ratio	6.6	9.3	8.6	8.7	3.9

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$-301M	$-201M	$-145M	$-134M	$-132M

Institutional owners (13F) 326 filers · $7.5B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 326

Value held $7.5B

New positions 54

Exited positions 22

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
54 (+4 vs prior Q)	22 (-12 vs prior Q)	130 (+17 vs prior Q)	83 (+3 vs prior Q)	+2.9M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
FMR LLC	$989,738,234	17,995,241	13.22%	Shares
Siren, L.L.C.	$526,625,715	9,575,013	7.03%	Shares
BlackRock, Inc.	$522,174,620	9,494,084	6.97%	Shares
SAMSARA BIOCAPITAL, LLC	$379,370,860	6,897,652	5.07%	Shares
WELLINGTON MANAGEMENT GROUP LLP	$369,989,675	6,727,085	4.94%	Shares
Orbis Allan Gray Ltd	$326,344,315	5,933,533	4.36%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$262,233,400	4,767,880	3.50%	Shares
STATE STREET CORP	$260,077,455	4,728,681	3.47%	Shares
Redmile Group, LLC	$237,110,060	4,311,092	3.17%	Shares
VANGUARD GROUP INC	$228,860,234	5,195,465	3.06%	Shares
NORGES BANK	$152,345,050	2,769,910	2.03%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$151,488,554	2,753,787	2.02%	Shares
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	$143,393,380	2,607,348	1.92%	Shares
Bellevue Group AG	$134,725,085	2,449,547	1.80%	Shares
JENNISON ASSOCIATES LLC	$129,722,285	2,358,587	1.73%	Shares
Hood River Capital Management LLC	$122,363,340	2,224,788	1.63%	Shares
Driehaus Capital Management LLC	$121,308,990	2,205,618	1.62%	Shares
EVENTIDE ASSET MANAGEMENT, LLC	$116,126,838	2,111,410	1.55%	Shares
JANUS HENDERSON GROUP PLC	$109,890,973	2,236,837	1.47%	Shares
Polar Capital Holdings Plc	$103,321,900	1,878,580	1.38%	Shares
Holocene Advisors, LP	$96,578,790	1,755,978	1.29%	Shares
ADAGE CAPITAL PARTNERS GP, L.L.C.	$95,227,110	1,731,402	1.27%	Shares
MORGAN STANLEY	$84,632,717	1,538,776	1.13%	Shares
Woodline Partners LP	$82,525,850	1,500,470	1.10%	Shares
GOLDMAN SACHS GROUP INC	$77,631,235	1,411,477	1.04%	Shares
Capital World Investors	$63,822,495	1,160,409	0.85%	Shares
Clearbridge Investments, LLC	$58,287,699	1,059,776	0.78%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$56,504,635	1,027,357	0.75%	Shares
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	$53,891,475	979,845	0.72%	Shares
AMERICAN CENTURY COMPANIES INC	$53,635,955	975,197	0.72%	Shares
NORTHERN TRUST CORP	$53,601,680	974,576	0.72%	Shares
BANK OF AMERICA CORP /DE/	$53,474,135	972,257	0.71%	Shares
Pictet Asset Management Holding SA	$50,106,164	911,075	0.67%	Shares
VOYA INVESTMENT MANAGEMENT LLC	$48,983,385	890,607	0.65%	Shares
FRANKLIN RESOURCES INC	$48,329,930	878,726	0.65%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$47,535,730	864,286	0.63%	Shares
Integral Health Asset Management, LLC	$41,250,000	750,000	0.55%	Shares
FEDERATED HERMES, INC.	$40,398,215	734,513	0.54%	Shares
VANGUARD FIDUCIARY TRUST CO	$40,154,565	730,083	0.54%	Shares
BNP PARIBAS FINANCIAL MARKETS	$39,463,160	717,512	0.53%	Shares
Rock Springs Capital Management LP	$39,349,860	715,452	0.53%	Shares
Casdin Capital, LLC	$36,575,000	665,000	0.49%	Shares
Nuveen, LLC	$35,846,195	651,749	0.48%	Shares
LOOMIS SAYLES & CO L P	$32,783,025	596,055	0.44%	Shares
Ensign Peak Advisors, Inc	$31,847,860	579,052	0.43%	Shares
Eagle Health Investments LP	$30,539,960	555,272	0.41%	Shares
UBS Group AG	$28,114,350	511,170	0.38%	Shares
Qube Research & Technologies Ltd	$25,505,150	463,730	0.34%	Shares
Fisher Asset Management, LLC	$24,169,585	439,447	0.32%	Shares
MARSHALL WACE, LLP	$23,677,500	430,500	0.32%	Shares

Show all 326 institutional owners →

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC, Srinivas Akkaraju ×4 filings	Oct. 7, 2025	7.20%	Amendment	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 28 insiders · 19 officers · 12 directors

19

Insider	Role	Last activity	Shares owned	Buys 12m	Sells 12m	Net 12m
David Hallal	Chief Executive Officer	Sept. 21, 2026 G	1,602,382	0	2	$-3,970,701
Jay T. Backstrom	CHIEF EXECUTIVE OFFICER	March 10, 2025 A	425,561	0	0	$0
Nagesh K. Manhathappa	Interim CEO and President	June 16, 2022 A	480,491	0	0	$0
Stuart A Kingsley	President and CEO	Feb. 1, 2021 A	42,000	0	0	$0
Vikas Sinha	Chief Financial Officer	April 16, 2026 S	619,856	0	2	$-1,231,462
Edward H Myles	COO & CFO	March 10, 2025 M	111,345	0	0	$0
Rhonda M. Chicko	Chief Financial Officer	Jan. 31, 2019 A	·	0	0	$0
Akshay Vaishnaw	President of R&D	April 16, 2026 S	630,542	0	2	$-1,479,737
Keith Woods	Chief Operating Officer	Sept. 24, 2026 G	572,021	0	2	$-1,221,659
Elan Ezickson	COO & Head of Corp.Development	May 29, 2018 A	·	0	0	$0
Mo Qatanani	CHIEF SCIENTIFIC OFFICER	Feb. 23, 2026 S	98,445	0	9	$-8,602,966
Caryn Parlavecchio	CHRO	Feb. 17, 2026 S	169,087	0	2	$-713,967
Junlin Ho	GENERAL COUNSEL	Feb. 17, 2026 S	241,545	0	2	$-802,309
Jing L. Marantz	CHIEF MEDICAL OFFICER	Feb. 17, 2026 S	126,012	0	2	$-451,320
Tracey Sacco	Chief Commercial Officer	April 25, 2025 M	71,750	0	0	$0
Erin Moore	Interim PFO and PAO	March 24, 2025 M	82,609	0	0	$0
Gregory John Carven	Chief Scientific Officer	June 16, 2022 A	128,208	0	0	$0
Yung H. Chyung	Chief Medical Officer	Feb. 14, 2022 A	258,496	0	0	$0
Alan J. Buckler	Chief Scientific Officer	Feb. 6, 2020 A	·	0	0	$0
Katie Peng	Director	July 1, 2026 S	34,301	0	5	$-337,751
Joshua Reed	Director	July 1, 2026 S	19,518	0	2	$-164,075
Jeffrey S. Flier	Director	July 1, 2026 S	27,856	0	3	$-164,491
Kristina Burow	Director	July 1, 2026 S	114,657	0	2	$-164,053
Michael Gilman	Director	July 1, 2026 S	59,511	0	3	$-137,058
Richard Brudnick	Director	June 4, 2026 A	21,896	0	0	$0
Srinivas Akkaraju	Director	June 4, 2026 A	27,971	9	0	$19,988,986
Amir Nashat	Director	May 9, 2024 J	38,639	0	0	$0
Timothy A. Springer	10% owner	Dec. 10, 2019 G	2,376,567	0	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 35 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
IBRN · iShares Trust	4.94%	6,638 SH	Sept. 11, 2026	Daily
GURU · Global X Funds	1.09%	14,083 NS	July 31, 2026	N-PORT
LABU · Direxion Shares ETF Trust	0.73%	76,534 NS	July 31, 2026	N-PORT
BBC · ETFis Series Trust I	0.72%	7,035 NS	July 31, 2026	N-PORT
IBB · iShares Trust	0.40%	737,768 SH	Sept. 11, 2026	Daily
IWO · iShares Trust	0.38%	988,363 SH	Sept. 11, 2026	Daily
IBBQ · Invesco Exchange-Traded Fund Trust …	0.38%	8,611 SH	Oct. 2, 2026	Daily
VTWG · VANGUARD SCOTTSDALE FUNDS	0.34%	112,682 SH	Aug. 19, 2026	Daily
ESSC · Strategy Shares	0.23%	1,785 NS	July 31, 2026	N-PORT
PWS · Pacer Funds Trust	0.21%	1,046 NS	July 31, 2026	N-PORT
IWM · iShares Trust	0.20%	2,857,880 SH	Sept. 11, 2026	Daily
VTWO · VANGUARD SCOTTSDALE FUNDS	0.19%	643,358 SH	Aug. 19, 2026	Daily
BKSE · BNY Mellon ETF Trust	0.17%	3,180 NS	July 31, 2026	N-PORT
RSSL · Global X Funds	0.17%	53,534 NS	July 31, 2026	N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0.16%	23,797 NS	July 31, 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0.06%	1,141,089 SH	Aug. 19, 2026	Daily
VHT · VANGUARD WORLD FUND	0.06%	224,721 SH	Aug. 19, 2026	Daily
ESML · iShares Trust	0.06%	29,351 SH	Sept. 11, 2026	Daily
FBCG · FIDELITY COVINGTON TRUST	0.05%	79,589 NS	July 31, 2026	N-PORT
ISCG · iShares Trust	0.05%	9,027 SH	Sept. 11, 2026	Daily
FHLC · FIDELITY COVINGTON TRUST	0.05%	35,479 NS	July 31, 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0.05%	26,694 SH	Oct. 2, 2026	Daily
WSML · iShares Trust	0.04%	5,311 SH	Sept. 11, 2026	Daily
VFMO · VANGUARD WELLINGTON FUND	0.02%	7,030 SH	Aug. 19, 2026	Daily
VTWV · VANGUARD SCOTTSDALE FUNDS	0.02%	5,664 SH	Aug. 19, 2026	Daily
VTI · VANGUARD INDEX FUNDS	0.01%	3,428,276 SH	Aug. 19, 2026	Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0.01%	89,618 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.01%	9,206 SH	Aug. 19, 2026	Daily
ESGV · VANGUARD WORLD FUND	0.01%	24,696 SH	Aug. 19, 2026	Daily
IWV · iShares Trust	0.01%	29,962 SH	Sept. 11, 2026	Daily
ITOT · iShares Trust	0.01%	134,626 SH	Sept. 11, 2026	Daily
TILT · FlexShares Trust	0.01%	3,402 NS	July 31, 2026	N-PORT
IWN · iShares Trust	·	62,011 SH	Sept. 11, 2026	Daily
ISCB · iShares Trust	·	3,926 SH	Sept. 11, 2026	Daily
ISCV · iShares Trust	·	13,116 SH	Sept. 11, 2026	Daily

SRRK Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 24 analysts BUY

Median target $71.50 +52.7%

9 37.5% Strong Buy

14 58.3% Buy

1 4.2% Hold

0 0.0% Sell

0 0.0% Strong Sell

12-Month Price Target

16 analysts · 2026-09-29

Mean target $70.44 +50.5%

← Below all targets Current price $46.81

Low$58.00 Mean$70.44 High$84.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
SRRK	$4.78B	-13.4	·	·	-157.9%	·
IOVA	$1.12B	-2.5	60.6%	-148.4%	-56.0%	·
GRAL	$3.45B	-7.7	17.2%	-277.5%	-16.7%	·
RYTM	$7.19B	-34.4	45.8%	-103.6%	-309.1%	·
CGON	$3.35B	-20.0	254.7%	-3985.0%	-22.6%	·
KOD	$1.73B	-6.5	·	·	-202.0%	·
ORKA	$1.48B	-3.3	·	·	-25.9%	·
MIRM	$4.10B	-168.1	54.7%	-4.5%	-8.2%	·
COGT	$5.72B	-16.4	·	·	-83.1%	·
TVTX	$3.47B	-131.8	110.5%	-5.2%	-34.6%	·
PTCT	$6.19B	9.8	114.5%	39.4%	-331.5%	·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

SRRK Scholar Rock Holding Corporation - Common Stock